Raissi Afsaneh, Bansal Aarushi, Ekundayo Oladapo, Bath Sehajroop, Edwards Nathaniel, Famure Olusegun, Kim Sang Joseph, Mucsi Istvan
Ajmera Transplant Center and Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Kidney Int Rep. 2022 Nov 13;8(2):282-293. doi: 10.1016/j.ekir.2022.11.002. eCollection 2023 Feb.
Older adults (65 years or older) constitute a substantial and increasing proportion of patients with kidney failure, potentially needing kidney replacement therapy. Living donor kidney transplant (LDKT) offers superior outcomes for suitable patients of all ages. However, exploring LDKT and finding a living donor could be challenging for older adults. Here, we assessed the association between age and utilization of LDKT and assessed effect modification of key variables such as ethnicity and language.
This is a retrospective cohort study of patients with kidney failure referred for kidney transplant (KT) assessment in Toronto between January 2006 and December 2013. The association between age and having a potential living donor identified was assessed using logistic regression and the association between age and the receipt of LDKT was assessed using Cox proportional hazards models.
Of the 1617 participants, 50% were middle-aged (45-64 years old), and 17% were ≥65 years old. In our final multivariable adjusted models, compared to young adults, middle-aged and older adults had lower odds of having a potential living donor identified (odds ratio [OR], 0.47; confidence interval [CI], [0.35-0.63]; OR, 0.30; CI, [0.20-0.43]; < 0.001, for middle-aged and older adults, respectively), and were less likely to receive LDKT (hazard ratio [HR], 0.79; CI, [0.63-0.99]; = 0.04; HR, 0.47; CI, [0.30-0.72]; = 0.001, for middle-aged and older adults, respectively.).
Age is an independent predictor of receiving LDKT. Considering that nearly 90% of patients with kidney failure in Canada are >45 years of age, these results point to important and potentially modifiable age-related barriers to LDKT.
老年患者(65岁及以上)在肾衰竭患者中所占比例相当大且呈上升趋势,可能需要肾脏替代治疗。活体供肾移植(LDKT)为所有年龄段的合适患者提供了更好的治疗效果。然而,对于老年患者而言,探索LDKT并找到活体供肾者可能具有挑战性。在此,我们评估了年龄与LDKT利用率之间的关联,并评估了种族和语言等关键变量的效应修正作用。
这是一项对2006年1月至2013年12月期间在多伦多因肾移植(KT)评估而转诊的肾衰竭患者进行的回顾性队列研究。使用逻辑回归评估年龄与确定潜在活体供肾者之间的关联,并使用Cox比例风险模型评估年龄与接受LDKT之间的关联。
在1617名参与者中,50%为中年(45 - 64岁),17%为65岁及以上。在我们最终的多变量调整模型中,与年轻成年人相比,中年人和老年人确定潜在活体供肾者的几率较低(优势比[OR]分别为0.47;置信区间[CI],[0.35 - 0.63];OR为0.30;CI为[0.20 - 0.43];中年人和老年人的P均<0.001),且接受LDKT的可能性较小(风险比[HR]分别为0.79;CI为[0.63 - 0.99];P = 0.04;HR为0.47;CI为[0.30 - 0.72];中年人和老年人的P均 = 0.001)。
年龄是接受LDKT的独立预测因素。鉴于加拿大近90%的肾衰竭患者年龄超过45岁,这些结果表明LDKT存在重要且可能可改变的与年龄相关的障碍。